Fig. 1
From: ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
ACE2 is downregulated in breast cancer tissue, and this downregulation is associated with worse prognosis. (a) Expression of ACE2 in breast cancer and normal tissues in the GEPIA database (n = 1197). (b) Expression of ACE2 mRNA in breast cancer and paired normal tissues (n = 29). (c) Kaplan-Meier curve of RFS stratified by the ACE2 level using the GEO database (n = 3951)